February is American Heart Month, a time to focus on our cardiovascular health and appreciate the incredible advancements in cardiac-related patient care.
In 1999, Troponin became the preferred biomarker for myocardial infarction. Next-generation high-sensitivity troponin tests were introduced to the U.S. market in 2017, resulting in advancements in the speed and precision of patient results.
High-sensitivity troponin cardiac tests allow for lower level detection of Troponin, helping to detect even minute heart injuries more quickly and accurately. A negative test can also rule out heart damage from coronary heart disease.
The speed and accuracy of diagnostics have a critical impact on patient outcome and cost of care. Thanks to these next-generation high-sensitivity troponins, clinicians are now able to diagnose or exclude a heart attack in just 1 hour, compared to older assay techniques which take more than 12 hours.1
Ensuring accurate patient results is crucial, but that couldn't be done without you! Here are a few ways to care for yourself during the month of February.
When time counts, you can feel confident in reporting your Cardiac assays to the ER when you have passed your Calibration Verification and Linearity studies. To learn more about our company Cardiac offerings or request more information, please email CDx-Sales@lgcgroup.com.